- Investing Ideas
- Swedish Pharmaceuticals & Biotech Pure Equity Growth
Swedish Pharmaceuticals & Biotech Pure Equity Growth
Results
3
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
3 companies
Camurus
Market Cap: SEK 32.8b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 551.00
7D
6.2%
1Y
-9.3%
BioArctic
Market Cap: SEK 27.9b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 314.00
7D
4.9%
1Y
72.8%
Bonesupport Holding
Market Cap: SEK 13.5b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 205.40
7D
-2.5%
1Y
-27.5%